The Treat-to-Target Project in Atopic Dermatitis: One Year On

Marjolein de Bruin-Weller; Mette Deleuran; Tilo Biedermann; Robert Bissonnette; Peter Foley; Giampiero Girolomoni; Jana Hercogová; Chih-Ho Hong; Norito Katoh; Andrew Pink; Marie-Aleth Richard; Stephen Shumack; Juan Francisco Silvestre; Jacob P. Thyssen; Stephan Weidinger

doi:10.2340/actadv.v103.5382

Acta Dermato-Venereologica (Apr 2023)

The Treat-to-Target Project in Atopic Dermatitis: One Year On

Marjolein de Bruin-Weller,
Mette Deleuran,
Tilo Biedermann,
Robert Bissonnette,
Peter Foley,
Giampiero Girolomoni,
Jana Hercogová,
Chih-Ho Hong,
Norito Katoh,
Andrew Pink,
Marie-Aleth Richard,
Stephen Shumack,
Juan Francisco Silvestre,
Jacob P. Thyssen,
Stephan Weidinger

Affiliations

Marjolein de Bruin-Weller: Department of Allergology and Dermatology, UMC Utrecht, National Expertise Center for Eczema, Utrecht, The Netherlands
Mette Deleuran: Department of Dermatology and Venereology, Aarhus University Hospital, Aarhus, Denmark
Tilo Biedermann: Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany
Robert Bissonnette: Innovaderm Research, Montreal, QC, Canada
Peter Foley: The University of Melbourne, St Vincent’s Hospital Melbourne, Melbourne, Australia; Probity Medical Research, Skin Health Institute, Melbourne, Victoria, Australia
Giampiero Girolomoni: Department of Medicine, Section of Dermatology and Venereology, University of Verona, Italy
Jana Hercogová: Institute of Clinical and Experimental Medicine, Prague, Czech Republic
Chih-Ho Hong: Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada
Norito Katoh: Department of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan
Andrew Pink: St John’s Institute of Dermatology, Guy’s and St, Thomas’ NHS Foundation Trust, London, UK; Department of Dermatology, Kings College, London, UK
Marie-Aleth Richard: CEReSSEA 3279, Research Center in Health Services and Quality of Life, Aix Marseille University, Marseille, France; Department of Dermatology, University Hospital of La Timone, Marseille, France; Dermatology Department, Assistance Publique Hôpitaux de Marseille, APHM, Marseille, France
Stephen Shumack: Department of Dermatology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Juan Francisco Silvestre: Department of Dermatology, Hospital General de Alicante, Alicante, Spain
Jacob P. Thyssen: Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
Stephan Weidinger: Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

DOI: https://doi.org/10.2340/actadv.v103.5382
Journal volume & issue: Vol. 103

Abstract

Read online

Atopic dermatitis is a chronic skin condition for which a range of systemic treatments have recently been approved. A treat-to-target strategy has been developed previously alongside an algorithm to guide the management of patients with atopic dermatitis. Here, we review the strategy and algorithm in the context of the evolving therapeutic landscape, and identify areas for further refinement and development.

Published in Acta Dermato-Venereologica

ISSN: 0001-5555 (Print); 1651-2057 (Online)
Publisher: Medical Journals Sweden
Country of publisher: Sweden
LCC subjects: Medicine: Dermatology
Website: https://medicaljournalssweden.se/actadv

About the journal

Abstract

Keywords